OncoRes Medical

Executive Summary

OncoRes Medical is an Australian med-tech startup advancing a novel intra-operative imaging system that combines optical coherence tomography (OCT) with quantitative micro-elastography (QME) to provide real-time, histology-grade tissue characterization during cancer surgery. The technology is designed to improve tumor margin assessment, potentially reducing re-excision rates and improving patient outcomes. Currently in preclinical development, OncoRes Medical has assembled a team of experts in medical imaging and oncology. The company is based in Perth, Australia, and operates in a high-need area of surgical oncology where accurate margin detection remains a challenge. With no disclosed funding rounds or commercial products yet, OncoRes Medical is at an early stage but holds promise due to its innovative approach and the growing demand for intra-operative guidance tools. The executive summary reflects the company's potential to address a significant clinical gap, pending successful translation through clinical trials and regulatory pathways.

Upcoming Catalysts (preview)

• Q4 2026First-in-human study initiation30% success
• Q2 2027Series A or significant funding round40% success
• Q3 2026Key opinion leader engagement or clinical collaboration50% success